We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors.
Global Transplant Diagnostics Market Report- Industry Insights, SWOT Analysis, Future Prospects - By Components Type, Technology, By Transplant Type, By Applications, By End-Users, By Region
Global Transplant Diagnostics Market Analysis, 2017-2025
With the introduction of novel diagnostic tests medical outcomes related with organ transplants have improved significantly in past few years. Moreover, organ refusal rate can be reduced by matching the donor and receiver compatibility before transplantation. Traditional procedures in transplant diagnostics comprise analysis of human leukocyte antigen (HLA). HLA analysis is completed in high-throughput laboratories with a limited staff, which is time consuming. However, presence of molecular assay technologies, such as sequencing techniques and PCR-based assays has proved to be efficient and significantly boosted the growth of global transplant diagnostics market.
Further, government initiatives are more likely to encourage organ transplantation alongside with awareness initiatives for the same is strengthening the growth of the transplant diagnostics market. For instance, initiatives by the European Commission for organ harvesting have given rise to availability of donated organs. Obtainability of the European donor card and cumulative consciousness among people have also amplified organ donation rate in the region. Likewise, U.S. has witnessed substantial growth in organ donations due to rising awareness.
Also, many companies are working on different business strategies to take the advantage of this growing arket and to grasp the significant market share of this industry. For instance, CareDx stated in a filing with the Securities and Exchange Commission that it has inked a authorizing and commercialization agreement with Illumina for the international distribution, development, and commercialization rights to Illumina's next-generation sequencing transplant clinical application products.
As per the analysis of global transplant diagnostics market conducted by Goldstein Research is anticipated to register a CAGR of 6.5% during the forecast period. In terms of value, the global transplant diagnostics market is anticipatedto reach a market valuation in excess of USD 1380.4 million by 2025 end.
Our report also provide with qualitative information on the factors mentioned below:
Market Penetration: Statistics regarding the competitive arena of the transplant diagnostics market
Market Sizing: The projected market size in 2025 and estimation of the market from 2017 to 2025
Product Development/Innovation: Comprehensive insights on forthcoming technologies, R&D activities, and innovative product launches in the transplant diagnostics market
Market Overview: Market dynamics and consequent analysis of accompanying trends as well as opportunities, drivers and challenges existing in the Transplant diagnostics market
Market Development: Complete information about rewarding markets – the study examines the market for drone logistics across various regions
Market Diversification: Thorough information about fresh products, untapped geographies, and investments in the Transplant diagnostics market
Regional Analysis: Factors manipulating market shares of North America, Europe, Asia Pacific, and the Middle East
Competitive Assessment: Exhaustive valuation of business strategies, products, and manufacturing capabilities of important market players
The local regulatory reforms and improvement strategies along with the forecast are clarified in each key point that indicates the general execution and issues in key areas, for example, the US, Asia Pacific, Middle East and Europe.
Key Players Mentioned In the Report
Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-LA Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup SSp AB, Qiagen N.V., Sigma-Aldrich and Thermo Fisher Scientific, Inc.
Transplant diagnostics Market, By Components Type
Reagents and Consumables
Software and Services
Transplant diagnostics Market, By Technology
Other PCR-Based Molecular Assays
Sequencing-Based Molecular Assays
Other Sequencing Molecular Assays
Transplant diagnostics Market, By Transplant Type
Solid Organ Transplantation
Other Organ Transplantations
Stem Cell Transplantation
Soft Tissue Transplantation
Transplant diagnostics Market, By Applications
Infectious Disease Testing
Transplant diagnostics Market, By End-Users
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Transplant diagnostics Market, By Region
Rest of Europe
Rest of Asia-Pacific
Middle East and Africa
Rest of Latin America
North America Accounts for the Highest Share in Global Transplant diagnostics Market
North America held over 30.0% share in the global market in 2017 owing to high adoption of advanced techniques and diagnostic tools, higher healthcare expenditure, and availability of skilled professionals. Further, presence of major market players in U.S, target population, and strong healthcare infrastructure in the region further reinforced the dominance of this region.
On the other hand, government regulation such as the Organ Transplantation Act that enforces restraints on compensation policies for organ donors is adversely distressing the market. The prevailing demand and supply gap in organ donation and the accessibility of alternatives for heart and liver transplants are limiting the market growth.
Reasons to Purchase Transplant diagnostics Market Report:
Facilitate decision-making based on strong historic and forecast data for transplant diagnostics market
Develop strategies based on the latest regulatory framework
Study on the region and country that are expected to dominate the market
Position yourself to gain the maximum advantage of the Transplant diagnostics market’s growth potential
Identify key partners and business development avenues across the globe
Respond to your competitors’ business structure, strategy and visions
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements